Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015-2016

首页> 外文期刊>Vaccine >Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015-2016

【24h】

Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015-2016

机译：中老年人和老年人13瓦斯和23例肺炎球菌接种疫苗接种的临床疗效：2015-2016的Epivac Cohort研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Clinical benefits using the 23-valent pneumococcal polysaccharide vaccine (PPsV23) or the 13-valent pneumococcal conjugate vaccine (PCV13) in adults are controversial. This study investigated clinical effectiveness for both PPsV23 and PCV13 in preventing pneumonia among middle-aged and older adults.

机译：背景：使用23价肺炎球菌多糖疫苗（PPSv23）或成人中的13价肺炎球菌缀合物疫苗（PCV13）的临床益处是有争议的。本研究研究了PPSV23和PCV13在中年和老年人中预防肺炎的临床效果。

著录项

来源
《Vaccine》 |2020年第5期|共11页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学免疫学;
关键词
Adults; Effectiveness; Pneumococcal conjugate vaccine; Pneumococcal polysaccharide vaccine; Pneumonia;

机译：成年人;有效性;肺炎球菌缀合物疫苗;肺炎球菌多糖疫苗;肺炎;

相似文献

外文文献
中文文献
专利

1. Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015-2016 [J] . Vaccine . 2020,第5期

机译：中老年人和老年人13瓦斯和23例肺炎球菌接种疫苗接种的临床疗效：2015-2016的Epivac Cohort研究
2. Evaluating clinical effectiveness of 13-valent pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study [J] . Angel Vila-Corcoles, Olga Ochoa-Gondar, Cinta de Diego, BMC Infectious Diseases . 2018,第1期

机译：评价加泰罗尼亚中年和老年人的13价肺炎球菌共轭疫苗预防肺炎的临床效果：EPIPAC队列研究的结果
3. Evaluating clinical effectiveness of 13-valent pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study [J] . Angel Vila-Corcoles, Olga Ochoa-Gondar, Cinta de Diego, BMC Infectious Diseases . 2018,第1期

机译：评价加泰罗尼亚中年和老年人的13价肺炎球菌共轭疫苗预防肺炎的临床效果：EPIPAC队列研究的结果
4. Evaluation of the effectiveness of a 13-valent pneumococcal conjugated vaccine implemented in the municipality of Campos de Goytacazes, Brazil [C] . Kury C.M.H., Vitral C.L, Kury M.M.H., World Congress of the World Society for Pediatric Infectious Diseases . 2014

机译：评估在巴西坎波德·戈科塔斯市政府实施的13价肺炎球菌共轭疫苗的有效性
5. Trajectories of risky sexual behavior, depressive symptoms, and substance use in a cohort of middle-aged and older adults in the Pitt Men's Study. [D] . Lim, Sin How. 2009

机译：在皮特男性研究中，中年和老年人队列中的危险性行为，抑郁症状和药物滥用的轨迹。
6. Evaluating clinical effectiveness of 13-valent pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study [O] . Angel Vila-Corcoles, Olga Ochoa-Gondar, Cinta de Diego, 2018

机译：评价加泰罗尼亚中年和老年人的13价肺炎球菌共轭疫苗预防肺炎的临床效果：EPIVAC队列研究的结果
7. A cost-effectiveness analysis of vaccinating older adults with the 23-valent pneumococcal polysaccharide vaccine (PPV23) compared to no vaccination, the 13-valent pneumococcal conjugate vaccine (PCV13), or PCV13 followed by PPV23 in Colombia [O] . E. Prieto, Y. Jiang, X. Yang, 2018

机译：与No疫苗接种，13价肺炎球菌缀合物疫苗（PCV13）或PCV13在哥伦比亚的PPV23之后，将疫苗过度成人接种疫苗接种成人疫苗（PPV23）疫苗接种疫苗接种疫苗（PPV23）

Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015-2016

摘要

著录项

相似文献

相关主题

期刊订阅